One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment

M.C.M. Bunck, A. Mari, A. Corner, B. Eliasson, R.M. Shaginian, R.J. Heine, Y.B. Wu, P. Yan, U. Smith, M.R. Taskinen, H. Yki-Jarvinen, M. Diamant

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)S7-S7
JournalDiabetologia
Volume52
Publication statusPublished - 2009

Cite this

Bunck, M. C. M., Mari, A., Corner, A., Eliasson, B., Shaginian, R. M., Heine, R. J., ... Diamant, M. (2009). One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment. Diabetologia, 52, S7-S7.
Bunck, M.C.M. ; Mari, A. ; Corner, A. ; Eliasson, B. ; Shaginian, R.M. ; Heine, R.J. ; Wu, Y.B. ; Yan, P. ; Smith, U. ; Taskinen, M.R. ; Yki-Jarvinen, H. ; Diamant, M. / One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment. In: Diabetologia. 2009 ; Vol. 52. pp. S7-S7.
@article{2348278deea54980ac6e08a5862f1c44,
title = "One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment",
author = "M.C.M. Bunck and A. Mari and A. Corner and B. Eliasson and R.M. Shaginian and R.J. Heine and Y.B. Wu and P. Yan and U. Smith and M.R. Taskinen and H. Yki-Jarvinen and M. Diamant",
year = "2009",
language = "Undefined/Unknown",
volume = "52",
pages = "S7--S7",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",

}

Bunck, MCM, Mari, A, Corner, A, Eliasson, B, Shaginian, RM, Heine, RJ, Wu, YB, Yan, P, Smith, U, Taskinen, MR, Yki-Jarvinen, H & Diamant, M 2009, 'One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment' Diabetologia, vol. 52, pp. S7-S7.

One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment. / Bunck, M.C.M.; Mari, A.; Corner, A.; Eliasson, B.; Shaginian, R.M.; Heine, R.J.; Wu, Y.B.; Yan, P.; Smith, U.; Taskinen, M.R.; Yki-Jarvinen, H.; Diamant, M.

In: Diabetologia, Vol. 52, 2009, p. S7-S7.

Research output: Contribution to journalMeeting AbstractOther research output

TY - JOUR

T1 - One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment

AU - Bunck, M.C.M.

AU - Mari, A.

AU - Corner, A.

AU - Eliasson, B.

AU - Shaginian, R.M.

AU - Heine, R.J.

AU - Wu, Y.B.

AU - Yan, P.

AU - Smith, U.

AU - Taskinen, M.R.

AU - Yki-Jarvinen, H.

AU - Diamant, M.

PY - 2009

Y1 - 2009

M3 - Meeting Abstract

VL - 52

SP - S7-S7

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

ER -